Matinas BioPharma Holdings Inc (MTNB)

0.664 -0.30 (-30.82%) USD  |  NYAM  |  Jan 08, 16:00
0.6603 0.00 (0.00%) After-Hours: 20:00
More

Matinas BioPharma Holdings SG&A Expense (Quarterly): 2.142M for Sept. 30, 2024

SG&A Expense (Quarterly) Chart

View SG&A Expense (Quarterly) for MTNB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense Definition

View SG&A Expense Definition
Start Trial

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

View SG&A Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (Quarterly) Benchmarks

View SG&A Expense (Quarterly) Benchmarks
Start Trial
Equillium Inc 3.278M
Tenon Medical Inc 2.976M
Alphatec Holdings Inc 109.20M
Merck & Co Inc 2.731B
Madrigal Pharmaceuticals Inc 107.58M